Free Newsletter
Counterfeiters lurk in free trade zones
Counterfeit drugmakers have found some unlikely allies: free trade zones. Set up by governments to promote trade, these zones have little regulatory oversight, and tariffs are waived. So it's relatively simple for counterfeiters to disguise the source of a drug, or to make and sell tainted products, according to a new investigation by the New York Times.
Recently, a stash of fake drugs was seized in a free trade zone in Dubai; the meds were destined for Americans who believed they were buying drugs from Canada, via an Internet pharmacy. It's a typical case of counterfeiters using one or more free trade zones to avoid detection.
Counterfeiting, of course, is a big threat to Big Pharma, because most of the fake drugs are tainted knockoffs of big-time brand name meds. And for patients, the fakes can be deadly.
- read the article from the New York Times
Related Articles:
Counterfeit drugs plaguing Big Pharma. Report
Chinese pharma recalls counterfeit drug. Report
FDA can't guarantee drug safety. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: